List view / Grid view
18 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
Software that can bypass current intellectual property and design medication with the same function as top drugs could help pharma companies...
18 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Erleada (apalutamide) has been approved for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
18 January 2019 | By European Pharmaceutical Review
A Phase I/IIa study has shown that arfolitixorin along with either irinotecan or oxaliplatin could shrink the size of tumours in colorectal cancer patients...
18 January 2019 | By Almac Group
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
17 January 2019 | By European Pharmaceutical Review
Combining benzodiazepines, opioids and Z-drugs could prove to cause serious adverse outcomes including breathing problems and fatalities...
17 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have developed a method that can use 3D microscopy to develop ALMOST, A Label-free Multicolor Optical Surface Tomography...
17 January 2019 | By
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
16 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness...
16 January 2019 | By European Pharmaceutical Review
As the date of implementing the FMD comes closer, organisations need to be ensuring compliance, whether in the EU or even after a possible no-deal Brexit...
16 January 2019 | By Nikki Withers (European Pharmaceutical Review)
The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation...
15 January 2019 | By European Pharmaceutical Review
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices...
15 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
A formulation of treprostinil as an inhaled dry powder has proven to be safe and effective, as reported in the safety analysis of a Phase III trial...
15 January 2019 | By NewAge Industries
NewAge Industries has reached another significant event in its history: 2019 marks the company’s 65th year in business...
15 January 2019 | By European Pharmaceutical Review
A team of university researchers have collaborated together to develop a method to produce the radioisotope Tc-99m in the US to prevent having to import it...
14 January 2019 | By European Pharmaceutical Review
Researchers have investigated back pain, and the disability, opioid and other medication use associated with it, to identify its course over time...
Follow: